• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

High cost of re-operation after breast-conserving surgery

Bioengineer by Bioengineer
December 19, 2018
in Cancer
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer.

A new BJS (British Journal of Surgery) analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings.

Using data from relevant published studies, the authors found the median hospital costs of women who needed re-operation were £4,511, £2,136 more than in women whose surgical margins were clear.

If these cost estimates are applied nationally, they provide compelling encouragement to seek interventions to minimize re-operation after BCS, which would reduce associated costs.

###

Media Contact
Josh Glickman
[email protected]
http://dx.doi.org/10.1002/bjs.11050

Tags: Breast CancerMedicine/HealthPublic HealthSurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Belzutifan for VHL Tumors: Single-Center Study

November 1, 2025

Myeloid Cell Signaling Identified as Key Driver of Immunotherapy Resistance in Kidney Cancer

October 31, 2025

October 31, 2025: MSK Research Breakthroughs Spotlighted

October 31, 2025

RNA modification m⁶A: A Crucial Factor in Cancer Progression and Treatment

October 31, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1294 shares
    Share 517 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    203 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Addressing Social Isolation in China’s Care Facilities

Digital HR Transformation Challenges in Bangladesh Healthcare

Advanced Techniques Boost Cancer Detection Accuracy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.